Analysis device and analysis method

The two-step method of membrane filtration and flushing addresses endotoxin adherence and reactivity issues, enabling high-accuracy detection of low-concentration endotoxins by ensuring complete flushing and optimized reagent use.

WO2026234970A1PCT designated stage Publication Date: 2026-11-12NOMURA MICRO SCI CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/015616
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-04-17
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing methods for detecting low concentrations of endotoxins in pharmaceutical water and drug manufacturing processes face challenges in reaction efficiency, accuracy, and sensitivity, with endotoxins adhering to filtration membranes and affecting membrane lifespan, and alkaline backwashing potentially impacting reactivity.

Method used

A two-step method involving membrane filtration for concentration and analysis, where endotoxins are accumulated on a filtration membrane and then flushed out for analysis, using a flow injection system with a reagent, and a switching mechanism to alternate between concentration and flushing.

Benefits of technology

Enables high-accuracy detection of low-concentration endotoxins by ensuring complete flushing of adhered endotoxins and optimizing reagent use, maintaining membrane integrity and analysis precision.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2026015616_12112026_PF_FP_ABST
    Figure JP2026015616_12112026_PF_FP_ABST
Patent Text Reader

Abstract

Provided are an analysis device and an analysis method with which an object under analysis can be accurately measured. The analysis device comprises: a flow injection system that causes an object under analysis and a reagent to react with each other in water, and analyzes the object under analysis by using the generated reactant; a membrane filtration device provided with a microfiltration membrane or an ultrafiltration membrane; a concentration mechanism that accumulates, in the membrane filtration device, the object under analysis in water; a flushing mechanism that causes the object under analysis accumulated in the membrane filtration device to flow to the flow injection system together with concentrated water from the membrane filtration device; a switching mechanism that switches between the concentration mechanism and the flushing mechanism; and a reagent injection unit that supplies the reagent to the flow injection system.
Need to check novelty before this filing date? Find Prior Art

Description

Analytical apparatus and analytical method

[0001] The present invention relates to an analytical apparatus and an analytical method.

[0002] Endotoxins (ETs) are microbial contaminants that require strict control in pharmaceutical water and drug manufacturing processes. They must be removed as much as possible, and online monitoring is essential. Traditionally, the Limulus test has been primarily used for endotoxin detection, but real-time online analysis has been difficult with this test.

[0003] Patent Document 1 describes a flow injection analysis (FIA) method in which a liquid-liquid mixture consisting of an organic phase and an aqueous phase is introduced into the inner tube of a double tube consisting of a porous polymer membrane inner tube and an outer tube enclosing the inner tube, or into a region surrounded by the inner and outer tubes, and only the organic phase is allowed to permeate through the wall of the porous polymer membrane inner tube to separate the organic phase from the aqueous phase, and the obtained organic phase is introduced into a detection unit to analyze the element to be tested. However, this method has been criticized for variations in the reaction efficiency of the reagents and the accuracy of the measurement, and in particular for insufficient detection sensitivity when detecting low concentrations of endotoxin.

[0004] Therefore, the inventors developed a method for detecting endotoxins online using flow injection analysis, employing a fluorescent reagent that specifically recognizes endotoxins and functions as a fluorescent label by binding to endotoxins (see, for example, Patent Document 2). Furthermore, they developed an analytical apparatus that enhances the quantitative accuracy of the analysis by concentrating endotoxins by cross-flow filtration of analyte water containing endotoxins at low concentrations using an ultrafiltration membrane (see, for example, Patent Document 3). In addition, a technique has been proposed in which a liquid is completely filtered using a filtration membrane to accumulate the particles on the membrane surface, and then recovered by backwashing, for example, to detect fine particles in a liquid (see, for example, Patent Document 4). In this technique, fine particles in the liquid are accumulated on the membrane surface by performing total filtration at a high flow rate using a large-area ultrafiltration membrane, and then the accumulated fine particles are detached from the membrane surface by backwashing the filtration membrane with alkaline functional water, and then recovered with a filtration membrane for capturing fine particles.

[0005] Japanese Unexamined Patent Publication No. 62-280652, Japanese Unexamined Patent Publication No. 2022-011525, Japanese Patent No. 7606197, Japanese Unexamined Patent Publication No. 2025-032796

[0006] However, the lower the concentration of endotoxin, the higher the concentration rate required, and therefore, in order to achieve sufficient concentration, the flow rate ratio of permeate water to concentrated water must be increased. The inventors have found that in the analysis of such low concentrations of endotoxin, the less concentrated water is used, the more the endotoxin adheres to the filtration membrane and becomes difficult to flush out. In particular, during long periods of continuous operation, there was a concern that the recovery of endotoxin adhering to and accumulating on the membrane surface would be insufficient, not only reducing the accuracy of endotoxin detection but also shortening the lifespan of the filtration membrane. Furthermore, when the technology described in Patent Document 4 is applied to the analysis of endotoxin, there was a concern that recovery would be insufficient even by backwashing. Moreover, the alkaline functional water used in backwashing may affect the physical properties of the endotoxin being detected, affecting its reactivity with the reagent and potentially making highly sensitive analysis difficult.

[0007] The present invention has been made to solve the above-mentioned problems and provides an analytical method and analytical apparatus that can detect analytes such as low concentrations of endotoxins with high accuracy.

[0008] To solve these problems, the inventors have found a two-step method: a concentration step in which endotoxins are concentrated in a membrane filtration device by membrane filtration, and an analysis step in which the concentrated endotoxins are sent to an analyzer for analysis. First, in the concentration step, the entire amount of the analyte is filtered to accumulate endotoxins in the membrane filtration device. Next, in the analysis step, the accumulated endotoxins are flushed out of the membrane filtration device. In this way, the endotoxins attached to the filtration membrane in the accumulation step can be flushed out of the membrane filtration device by flushing in the analysis step, making it possible to measure highly concentrated analytes with high accuracy.

[0009] The present invention has been made based on the above-mentioned studies, and embodiments of the present invention have the following configurations: [1] An analytical apparatus characterized by comprising: a flow injection system for reacting an analyte with a reagent in water and analyzing the analyte using the reaction product generated; a membrane filtration device equipped with a microfiltration membrane or an ultrafiltration membrane; a concentration mechanism for accumulating the analyte in water within the membrane filtration device; a flushing mechanism for flowing the analyte accumulated in the membrane filtration device together with the concentrated water from the membrane filtration device into the flow injection system; a switching mechanism for switching between the concentration mechanism and the flushing mechanism; and a reagent injection unit for supplying the reagent to the flow injection system. The analytical apparatus may also have the following configurations. [1] The analytical apparatus comprising: a flow injection system for reacting an analyte with a reagent in water and analyzing the analyte using the resulting reaction product; a membrane filtration device equipped with a hollow fiber microfiltration membrane or a hollow fiber ultrafiltration membrane; a concentration mechanism configured to form a flow path for analyte water so as to accumulate the analyte in water within the membrane filtration device; a flushing mechanism configured to form a flow path for analyte water so as to flow the analyte accumulated in the membrane filtration device together with the concentrated water from the membrane filtration device into the flow injection system; a switching mechanism for switching between the concentration mechanism and the flushing mechanism; and a reagent injection unit for supplying the reagent to the flow injection system. [2] The analytical apparatus according to [1], wherein the concentration mechanism performs total filtration with the membrane filtration device. [3] The analytical apparatus according to [1], wherein the flushing mechanism flows the entire amount of the supply water from the membrane filtration device to the flow injection system from the concentration side. [4] The analytical apparatus according to [1], wherein the flushing mechanism flows 50% or more of the supply water from the membrane filtration device to the flow injection system as concentrated water. [5] The analytical apparatus according to [4], wherein the reagent injection unit injects the reagent into the reagent line. [6] The analytical apparatus according to [1], wherein the flushing mechanism is a backwashing mechanism that supplies water from the permeate side of the membrane filtration device and discharges the analyte from the concentration side of the membrane filtration device.[7] The flow injection system is an analytical apparatus according to any one of [1] to [6] that is capable of quantitatively analyzing the analyte. [8] An analytical method for analyzing an analyte using a reaction product produced by reacting the analyte with a reagent in water, comprising: a concentration step of accumulating the analyte on a filtration membrane using one or more filtration membranes selected from microfiltration membranes and ultrafiltration membranes; and an analysis step of flowing the reagent into the flow injection system while flowing the accumulated analyte together with the concentrated water from the filtration membrane into the flow injection system. This analytical method may also have the following configuration: An analytical method for analyzing an analyte using a reaction product produced by reacting the analyte with a reagent in water, comprising: a concentration step of accumulating the analyte on a filtration membrane using one or more filtration membranes selected from hollow fiber microfiltration membranes and hollow fiber ultrafiltration membranes; and an analysis step of flowing the reagent into the flow injection system while flowing the accumulated analyte together with the concentrated water from the filtration membrane into the flow injection system. [9] The analytical method according to [8], wherein the entire volume is filtered through the filtration membrane in the concentration step.

[10] The analytical method according to [8], wherein the reagent is flowed through the flow injection system together with the permeate from the filtration membrane.

[11] The analytical method according to [8], wherein the entire volume of the water supplied to the filtration membrane is flowed through the flow injection system as the concentrated water in the analytical step.

[12] The analytical method according to any one of [8] to

[11] , wherein the analytical method is capable of quantitative analysis of the analyte. The symbol "~" indicates a numerical range including the numbers before and after it.

[0010] According to the analytical apparatus and analytical method of the present invention, it is possible to measure the target of analysis with high accuracy.

[0011] This is a diagram showing an analytical apparatus according to an embodiment of the present invention. This is a diagram showing an analytical apparatus according to another embodiment of the present invention. This is a diagram showing an analytical apparatus according to another embodiment of the present invention. This is a diagram showing an analytical apparatus according to another embodiment of the present invention. This is a diagram showing an analytical apparatus according to another embodiment of the present invention. This is a graph schematically showing the concentration change of concentrated water measured by the analytical apparatus of the present invention and the analytical apparatus of the prior art.

[0012] Embodiments of the present invention will be described below with reference to the drawings.

[0013] Figure 1 is a diagram showing an analytical apparatus 12 according to an embodiment of the present invention. The analytical apparatus 12 shown in Figure 1 analyzes microbial substances and fungi (live bacteria themselves) contained in the water to be analyzed. That is, the analytical apparatus 12 of this embodiment can detect the analyte in the water to be analyzed (qualitative analysis) or measure the concentration of the analyte in the water to be analyzed (quantitative analysis). The microbial substance is, for example, endotoxin, which is a lipopolysaccharide that constitutes the cell wall of Gram-negative bacteria.

[0014] Examples of water to be analyzed include pharmaceutical water such as water for injection (WFI) and purified water, and semiconductor manufacturing water such as pure water and ultrapure water. The water to be analyzed may also be water collected during the manufacturing process of the above-mentioned pharmaceutical water or semiconductor water. The water to be analyzed can be collected from a water treatment system. Examples of water treatment systems include a purified water production system, a water for injection production system, and a pure water production system or ultrapure water production system for semiconductor water.

[0015] The analytical apparatus 12 according to this embodiment includes a concentration mechanism for concentrating the analyte and an analytical mechanism (flushing mechanism) for analyzing the concentrated analyte. The analytical apparatus 12 further includes a switching mechanism for switching between the concentration mechanism and the analytical mechanism. For example, the concentration mechanism and the analytical mechanism consist of one or more valves that can be opened and closed, and one or more pipes that constitute the flow paths for the analyte water and the flushing water. In this specification, the "concentration mechanism" includes a configuration for forming a flow path to concentrate the analyte. The "analytical mechanism" also includes a configuration for forming a flow path to analyze the analyte. The switching mechanism is, for example, a control device that switches the flow path by controlling the opening and closing of each valve, and the concentration mechanism and the analytical mechanism can be switched by this control device.

[0016] The analyzer 12 includes a pre-concentration pump 14, a membrane filtration device 16, and piping 18 connected to the inlet side of the membrane filtration device 16. The pre-concentration pump 14 is located in the path of the piping 18, and the water to be analyzed (supply water) is sent from the water treatment system to the pre-concentration pump 14. Here, supply water refers to the water to be analyzed supplied to the membrane filtration device 16. The pre-concentration pump 14 pressurizes the water to be analyzed. The pressurized water to be analyzed is sent through the piping 18 to the downstream membrane filtration device 16. For example, when the analyzer 12 is connected to the sampling line of a purified water production system or an ultrapure water production system for online analysis, the pre-concentration pump 14 can be omitted if the pressure (water pressure) of the sampling line is at an appropriate pressure for sending the water to the downstream stage. Also, if the pressure of the sampling line is too high compared to the appropriate pressure, a pressure reducing means such as a pressure reducing valve can be installed instead of the pre-concentration pump 14. The analyzer 12 can measure the target of analysis online or offline, and online measurement is preferred.

[0017] The membrane filtration apparatus 16 has an outer cylinder 20. An ultrafiltration membrane 30 is arranged inside the outer cylinder 20. A microfiltration membrane may be used instead of the ultrafiltration membrane. The pore size of the ultrafiltration membrane 30 is large enough to capture bacterial-derived substances as the analyte, and its molecular weight cutoff is generally 1 kDa to 100 kDa. The pore size of the microfiltration membrane is large enough to capture fungi as the analyte, and is generally 0.1 μm to 0.5 μm. As the ultrafiltration membrane or microfiltration membrane, a membrane that removes 90% or more of the analyte is more preferable, and a membrane that removes 95% or more is even more preferable.

[0018] The material for the ultrafiltration membrane 30 can be any material used for ultrafiltration membranes, such as cellulose acetate, polyacrylonitrile, polysulfone, polyethersulfone, modified polyethersulfone, polyvinylidene fluoride, etc. Polyacrylonitrile, polysulfone, polyethersulfone, modified polyethersulfone, and polyvinylidene fluoride are preferred as materials for the ultrafiltration membrane 30. Among these, modified polyethersulfone is particularly preferred as the material for the ultrafiltration membrane. Because modified polyethersulfone has high hydrophilicity, fine particles adsorbed onto the membrane surface of the ultrafiltration membrane 30 are easily detached from the membrane surface. Therefore, it is preferable because the fine particles accumulated in the concentration step described later can be easily discharged from the ultrafiltration membrane 30 in the subsequent analysis step. The pore size of the ultrafiltration membrane 30 used in the membrane filtration apparatus 16 is large enough to capture fine particles; for example, the molecular weight cutoff is preferably in the range of 1 kDa to 100 kDa. Furthermore, the shape of the ultrafiltration membrane 30 is usually hollow fiber. The effective membrane area of ​​the ultrafiltration membrane 30 is 100 mm². 2 Above 1000mm 2 The following ranges are preferred. The pore size, shape, or effective membrane area characteristics of the ultrafiltration membrane 30 described above make it easier to measure the endotoxin concentration in relatively small amounts of supply water, as described later. Although the reason is not clear, endotoxins tend to detach easily from the UF membrane (ultrafiltration membrane). One possible reason for this phenomenon is that while fine particles are almost spherical and have a uniform charge on their surface, endotoxins have an elongated shape and show charge unevenness at both ends.

[0019] A commercially available membrane filtration device 16 can be used. Examples of commercially available products using ultrafiltration membranes include Repligen's MIDIKROS (trade name) MPES (modified polyethersulfone).

[0020] An inlet 22 is provided at one end of the outer cylinder 20 of the membrane filtration device 16 in the longitudinal direction, and an outlet 24 is provided at the other end. Furthermore, a discharge section 26 is provided on the outer circumference of the outer cylinder 20. Piping 18 is connected to the inlet 22. A first pipe 32 is connected to the outlet 24. One end of a discharge pipe 31 is connected to the discharge section 26. A second valve 62 is provided on the discharge pipe 31. A first valve 60 is provided in the path of the first pipe 32, and furthermore, a flow injection system 40 is connected to the downstream side of the first valve 60 of the first pipe 32.

[0021] In the membrane filtration apparatus 16, the outlet 24 is provided on the concentration side of the ultrafiltration membrane 30, and the concentrated water from the ultrafiltration membrane 30 is sent from the outlet 24 to the first pipe 32. The discharge 26 is provided on the permeate side of the ultrafiltration membrane 30, and the permeate water from the ultrafiltration membrane 30 is sent to the discharge 26.

[0022] With these configurations, the concentrated water from the membrane filtration device 16 is sent to the flow injection system 40 as sample water through the first pipe 32.

[0023] The flow injection system 40 has a sample water line and a reagent line, and a pump provided within the flow injection system 40 mixes the sample water and reagent by synchronizing the supply from the sample water line and the reagent line. The first pipe 32 that carries the sample water constitutes the sample water line. The flow injection system 40 is connected to a second pipe 34 for supplying reagents to the flow injection system 40, and the second pipe 34 constitutes the reagent line. A reagent injection unit 44 that injects reagents into the second pipe 34 is connected to the second pipe 34. The reagent injection unit 44 consists of, for example, a chemical injection pump that quantifies and delivers the reagent, and a pipe that supplies the reagent delivered by the chemical injection pump to the second pipe 34. Alternatively, a loop pipe 70 that bypasses the connection between the reagent injection unit 44 and the second pipe 34 may be connected between the reagent injection unit 44 and the second pipe 34, allowing switching between a direct flow path from the reagent injection unit 44 to the second pipe 34 and a flow path from the reagent injection unit 44 to the second pipe 34 via the loop pipe 70. By sending the reagent injected into the reagent injection unit 44 to the second pipe 34 via the loop tube 70, the time it takes for the reagent to reach the flow injection system 40 can be delayed compared to when the reagent is injected directly from the reagent injection unit 44 to the second pipe 34. The timing of the injection of reagent supplied to the flow injection system 40 can be adjusted by adjusting the length of the loop tube 70.

[0024] The timing of reagent injection may be controlled by the reagent injection unit 44. For example, by considering the change in the concentration of the analyte in the sample water flowing through the analyzer 48 when analysis is performed, and controlling the injection timing so that the reagent is added at the moment when the concentration of endotoxin in the concentrated water is at its maximum (the peak of endotoxin concentration), high analytical accuracy can be achieved while suppressing reagent consumption. Alternatively, the timing of reagent injection may be controlled by adjusting the length of the loop tube 70 so that the reagent is supplied between the rise of the endotoxin concentration peak and the convergence of the peak. Reagent injection may also be controlled by program control.

[0025] With these configurations, the reagent injected from the reagent injection unit 44 into the second pipe 34 is sent to the flow injection system 40. The reaction product generated by the reaction between the sample water and the reagent within the flow injection system 40 is then analyzed by the analyzer 48 within the flow injection system 40. Other components of the flow injection system 40 will be described later.

[0026] The analytical apparatus 12 of this embodiment includes a bypass pipe 80 connecting the path of the first pipe 32 and the path of the second pipe 34. The bypass pipe 80 is equipped with a third valve 64. Alternatively, a three-way valve may be provided at the connection between the first pipe 32 and the bypass pipe 80 instead of the first valve 60 and the third valve 64. Furthermore, the first valve 60, the second valve 62, and the third valve 64 may be variable-opening valves or on / off valves, and their opening or closing or opening degree may be automatically controlled by a control device or the like. The same applies to the other valves described later. Each valve may also be a multi-way valve. If a multi-way valve is used, it is possible to group multiple valves that are in close proximity together.

[0027] Next, an analysis method using the analysis device 12 will be described. The analysis method of this embodiment has a concentration step and an analysis step. First, in the concentration step, the second valve 62 is opened, the first valve 60 is closed, and the third valve 64 is opened. Then, the water to be analyzed is supplied to the membrane filtration device 16 via the piping 18 by the pre-concentration pump 14. Ultrapure water (or water for injection, the same applies hereinafter) is supplied to the second piping 34.

[0028] The supplied water to be analyzed is filtered entirely by the membrane filtration device 16, and the analytes contained in the water are accumulated in the membrane filtration device 16. The permeate from the membrane filtration device 16 is discharged out of the system via the discharge pipe 31. During this time, the injection of reagents from the reagent injection unit 44 is stopped. The ultrapure water supplied to the second pipe 34 is supplied to the flow injection system 40 via the second pipe 34, the bypass pipe 80, and the first pipe 32. At this time, the flow path of the water to be analyzed, formed by the open second valve 62, the closed first valve 60, and the open third valve 64, constitutes the concentration mechanism. In the concentration process, when ultrapure water is supplied to the second pipe 34, the ultrapure water is sent to the flow injection system 40 from the bypass pipe 80 through the first pipe 32. Normally, the flow injection system 40 requires a start-up operation to flow the solvent before starting the measurement, but by flowing ultrapure water into the flow injection system 40 during the concentration process, the analysis process can be performed immediately after the concentration process without going through a start-up operation. In the concentration process, the flow rate of the concentrated water in the membrane filtration device 16 is preferably 3% or less of the flow rate of the supply water, more preferably 1% or less, and the concentration process is even more preferably a total filtration process in which the concentrated water is not discharged. In the storage process, total filtration allows for more accurate measurement of the concentration of the analyte, but if the flow rate of the concentrated water is within the above-mentioned preferred range, the concentration of the analyte can be measured with the same accuracy as in the case of total filtration.

[0029] In the concentration process, the supply flow rate of the ultrapure water to be measured is preferably 10 mL / min or more and 500 mL / min or less. A more preferable range is 50 mL / min or more and 400 mL / min or less. An even more preferable range is 100 mL / min or more and 300 mL / min or less. The analyzer 12 of this embodiment is suitable for measurement at relatively small flow rates as described above, and in this case, it is easier to exhibit excellent effects. Furthermore, the supply flux is preferably 0.1 mm / min or more and 55 mm / min or less. A more preferable flux is 0.5 mm / min or more and 40 mm / min or less. An even more preferable flux is 1 mm / min or more and 35 mm / min or less.

[0030] By performing a concentration process for a predetermined period, the analytes in the analyte water that has passed through the membrane filtration device 16 during that period are accumulated in the membrane filtration device 16. Subsequently, the analysis process is performed. In the analysis process, with the analyte water and ultrapure water being supplied to the analyzer 12, the second valve 62 is closed, the first valve 60 is opened, and the third valve 64 is closed. These valve operations switch the flow path, and the analytes accumulated in the membrane filtration device 16 during the concentration process are pushed out by the newly supplied analyte water and sent to the flow injection system 40 as sample water via the first pipe 32. At the same time, the reagent injection unit 44 is activated to supply reagents into the second pipe 34. As a result, ultrapure water containing reagents is supplied to the flow injection system 40 as carrier water. Then, the reaction product generated by the reaction between the sample water and reagents in the flow injection system 40 is analyzed for the analyte by the analyzer 48 in the flow injection system 40. At this time, the flow path of the water to be analyzed, formed by the closed second valve 62, the open first valve 60, and the closed third valve 64, constitutes the flushing mechanism.

[0031] Note that the flow rate of the analysis target water flowing through the first pipe 32 in the analysis step is preferably 50% or more and 100% or less of the supply flow rate of the analysis target water to the membrane filtration device 16. When the flow rate of the analysis target water flowing through the first pipe 32 in the analysis step is 50% or more of the supply flow rate of the analysis target water to the membrane filtration device 16, the entire analyte accumulated in the membrane filtration device 16 can be caused to flow into the flow injection system 40 without leaving any residue. When the flow rate of the analysis target water flowing through the first pipe 32 in the analysis step is 100% or less of the supply flow rate of the analysis target water to the membrane filtration device 16, the analyte accumulated in the membrane filtration device 16 can be caused to flow into the flow injection system 40 without being mixed with the newly supplied analysis target water, so that the accuracy of quantitative analysis can be improved. In addition, the supply flow rate to the membrane filtration device can be varied between the concentration step and the analysis step. In the present embodiment, by closing the valve 62 during the analysis step, the flow rate of the permeated water (drainage side) is made substantially zero, or backwashing is performed with water that does not affect the analyzer such as pure water, whereby most of the endotoxin concentrated on the membrane surface can be flushed to the measurement side.

[0032] Note that the supply flow rate of the analysis target water to the membrane filtration device 16 in the analysis step is preferably 50% or more and 300% or less of the supply flow rate of the analysis target water in the concentration step. When the supply flow rate of the analysis target water in the analysis step is 50% or more of the supply flow rate of the analysis target water in the concentration step, the entire analyte accumulated in the membrane filtration device 16 can be caused to flow into the flow injection system 40 without leaving any residue. When the supply flow rate of the analysis target water in the analysis step is 300% or less of the supply flow rate of the analysis target water in the concentration step, the analyte accumulated in the membrane filtration device 16 can be caused to flow into the flow injection system 40 without being mixed with the newly supplied analysis target water, so that the accuracy of quantitative analysis can be improved.

[0033] The supply flow rate of the analysis target water can be adjusted by the discharge pressure of the pre-concentration pump 14. In addition, the flux may be temporarily increased at the start of flushing (at the start of the analysis step) to promote the peeling of endotoxin accumulated on the surface of the ultrafiltration membrane 30.

[0034] The volume of the water to be analyzed supplied to the membrane filtration device 16 in the concentration step and the analysis step, and the time of each step may be adjusted according to the assumed concentration of the analysis target, or the height of the concentration peak measured by the analyzer 48 in the analysis step. For example, when the endotoxin concentration is low, the period of the concentration step may be set longer, and when the endotoxin concentration is high, the period of the concentration step may be set shorter. In addition, these may be adjusted by automatically controlling the valves by the above-mentioned control device. Furthermore, the input amount and input timing of the reagent may be appropriately adjusted according to changes such as the assumed concentration of the analysis target or the height of the peak concentration. By adjusting the reagent input conditions in this way, the reagent use efficiency can be optimized, and the analysis accuracy can be improved.

[0035] In the analysis method using the analyzer 12, the analysis target in a predetermined amount of water to be analyzed is concentrated in the concentration step, and then the concentrated water containing the analysis target at a high concentration can be caused to flow into the flow injection system 40 as sample water. Therefore, a low-concentration analysis target can be analyzed with high accuracy. In addition, by matching the injection of the reagent from the reagent injection unit 44 with the timing at which the concentrated sample water of the analysis target flows in the analysis step, the amount of reagent used can be reduced.

[0036] The concentration of endotoxin, which is the measurement target of the present embodiment, is preferably 0.001 EU / mL or more and 1 EU / mL or less. When adsorbed or captured on the membrane surface in a highly dispersed state, it can be easily desorbed from the membrane surface. The endotoxin concentration is 10 10 units / mL or less, which facilitates maintaining high dispersion in water, and the endotoxin is accumulated in the ultrafiltration membrane 30 in the accumulation step in a highly dispersed state. In addition, the adsorption amount of endotoxin to the membrane at this time is 8.3 × 10 per unit area -13 g / cm 2 to 8 × 10 ―6 g / cm 2 .

[0037] As described above, the analytical apparatus 12 according to this embodiment can supply concentrated sample water of the analyte to the flow injection system 40 by combining a concentration process and an analysis process, thereby enabling high-precision analysis of the analyte. Furthermore, it enables the analysis of low concentrations of the analyte while reducing the amount of reagent used.

[0038] Furthermore, the analytical apparatus 12 according to this embodiment is capable of alternately executing the concentration process and the analysis process at predetermined time intervals or according to measurement conditions. Therefore, continuous measurement becomes possible by measuring the analyte concentrated in the concentration process with high precision in the analysis process, and then returning to the concentration process. The time interval at which the processes are switched may be adjusted as appropriate according to changes in the measurement results. These process switches can be performed by controlling operations such as valve opening and closing and pump control using a switching mechanism.

[0039] Next, the flow injection system 40 will be described. The flow injection system 40 includes a pump 42 provided in common or separately to the first pipe 32 and the second pipe 34, a confluence pipe 46 that merges the first pipe 32 and the second pipe 34 downstream of the pump 42, and an analyzer 48 connected to the confluence pipe 46. The sample water and reagent that have passed through the pump 42 are mixed in the confluence pipe 46. This causes the analyte in the sample water to react with the reagent in the carrier water. The reaction product of the analyte and reagent is then sent to the analyzer 48. Since the amounts of the analyte and the reaction product are correlated, the concentration of the analyte is measured by the analyzer 48 measuring the reaction product.

[0040] Pump 42 is, for example, a plunger pump. In this plunger pump, the plunger reciprocates within the pump housing to pressurize the fluid and send it from the upstream side to the downstream side. Preferably, pump 42 is a double plunger pump having two plungers arranged in parallel. The double plunger pump is provided in common to the first piping 32 and the second piping 34. Pump 42 is capable of sending the sample water and carrier water downstream in sync with their pressurization cycles. Pump 42 may also be a peristaltic pump, a syringe pump, or a solenoid pump. It is more preferable that pump 42 is a plunger pump.

[0041] When the target of analysis is endotoxin, a fluorescent reagent described in Japanese Patent Publication No. 2022-011525, in which a fluorescent site and a recognition site are bonded by a spacer, can be used as the reagent, but is not limited to this. The fluorescent reagent is activated by the reaction of endotoxin with the above-mentioned fluorescent reagent. Inside the analyzer 48, there are pipes (not shown) and a quartz cell connected to the pipes. The analyzer 48 irradiates light onto the combined water flowing through the quartz cell, causing the activated reagent to generate fluorescence. The analyzer 48 can measure the concentration of endotoxin by detecting the signal intensity of this fluorescence. The analyzer 48 has an outlet pipe 50 for discharging the combined water after analysis.

[0042] The analyzer 48 irradiates the water to be analyzed with excitation light having a wavelength of 340 to 360 nm, for example, and quantifies the activated reagent by observing the fluorescence generated at 440 to 520 nm. The analyzer 48 analyzes the concentration of endotoxin from the amount of reagent quantified. In the analyzer 48, a flow rate of 0.01 to 4.00 mL / min of sample water is preferable for improving measurement accuracy.

[0043] The materials of the first pipe 32, the second pipe 34, and the confluence pipe 46 are not limited as long as they can carry the sample water, carrier water, and confluence water, respectively. The material of the piping for the analyzer 48 is not particularly limited, but for example, fused silica tubing is used. Because fused silica tubing has extremely low reactivity with activated reagents, using fused silica tubing enables more accurate analysis of endotoxins.

[0044] Figure 2 shows an analytical apparatus 121 of another embodiment of the present invention. In the analytical apparatus 121, reagents are continuously supplied to the flow injection system 40 throughout the concentration and analysis processes. As shown in Figure 2, the analytical apparatus 121 has an ultrapure water pipe 82 connected to the first pipe 32 instead of the bypass pipe 80 of the analytical apparatus 12 shown in Figure 1, and a third valve 64 is provided in the ultrapure water pipe 82. In the concentration process, the third valve 64 can be opened to supply ultrapure water to the flow injection system 40 through the ultrapure water pipe 82. In the analysis process, the third valve 64 can be closed to stop the supply of ultrapure water, thereby supplying only sample water to the flow injection system 40. Furthermore, throughout the concentration and analysis processes, reagents are continuously supplied from the reagent injection unit 44 to the flow injection system 40 through the second pipe 34, making it possible to mix the reagents with the sample water.

[0045] Next, with reference to Figure 3, a case in which the permeate from the membrane filtration device 16 is used as carrier water will be described. Figure 3 is a diagram showing an analyzer 122 of another embodiment of the present invention. In the analyzer 122, a discharge section 26 and a water supply section 28 are provided on the outer circumference of the outer cylinder 20 of the membrane filtration device 16. A third pipe 36 is connected to the water supply section 28. The opposite side of the third pipe 36 from the water supply section 28 is connected to a pump 42 of the flow injection system 40. Similar to the second pipe 34 of the analyzer 12 shown in Figure 1, a reagent injection section 44 for injecting reagents into the third pipe 36 is connected to the third pipe 36. A loop pipe 70 that bypasses the connection between the reagent injection section 44 and the third pipe 36 may be connected between the reagent injection section 44 and the third pipe 36.

[0046] In the analytical apparatus 122 shown in Figure 3, during the concentration process, the second valve 62 is opened and its opening is reduced. The first valve 60 is closed, and the third valve 64 is opened. Then, the water to be analyzed is supplied to the membrane filtration apparatus 16 via the piping 18 by the pre-concentration pump 14.

[0047] The water to be analyzed supplied to the membrane filtration device 16 is completely filtered by the membrane filtration device 16, and the analytes contained in the water are accumulated within the membrane filtration device 16. A portion of the permeate from the membrane filtration device 16 is discharged outside the system via the discharge pipe 31, and the remainder is sent to the flow injection system 40 via the third pipe 36. During this time, the injection of reagents from the reagent injection unit 44 is stopped. The permeate supplied to the third pipe 36 is supplied to the flow injection system 40 via the third pipe 36, the bypass pipe 80, and the first pipe 32. At this time, the flow path of the water to be analyzed, formed by the second valve 62 with its opening degree adjusted, the first valve 60 being closed, and the third valve 64 being open, constitutes the concentration mechanism.

[0048] Regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the third pipe 36 may be connected upstream of the second valve 62 of the discharge pipe 31, thereby sending a portion of the permeate from the concentration process to the third pipe 36 and flowing it into the flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the discharge pipe 31 may be connected upstream of the reagent injection unit 44 of the pipe 36 via the second valve 62, thereby discharging a portion of the permeate outside the system through the discharge pipe 31.

[0049] A concentration process is performed for a predetermined period, followed by an analysis process. During the analysis process, with the water to be analyzed being supplied to the analyzer 122, the second valve 62 is closed, the first valve 60 is opened, and the third valve 64 is closed. The analytes accumulated in the membrane filtration device 16 during the concentration process are pushed out by the newly supplied water to be analyzed and sent to the flow injection system 40 as sample water via the first pipe 32. At the same time, the permeate from the membrane filtration device 16 flows out into the third pipe 36, and the reagent injection unit 44 is activated to supply reagents into the third pipe 36. As a result, the permeate containing reagents is supplied to the flow injection system 40 via the third pipe 36 as carrier water. At this time, the flow path of the water to be analyzed formed by the closed second valve 62, the restricted opening of the first valve 60, and the closed third valve 64 constitutes a flushing mechanism. In this embodiment, it is preferable that the inner diameters of the first pipe 32 and the third pipe 36 be adjusted so that the concentrated water flow rate / persistent water flow rate of the membrane filtration device 16 in the analysis process is in the range of 1 to 30. Furthermore, a flow meter can be installed near the inlet of the first pipe 32, and when the flow rates in the first pipe 32 and the third pipe 36 become similar, the detection results can be corrected based on the value of the flow meter.

[0050] Figure 4 shows an analytical apparatus 123 of another embodiment of the present invention. In the analytical apparatus 123, reagents are continuously supplied to the flow injection system 40 throughout the concentration and analysis processes. As shown in Figure 4, the analytical apparatus 123 has a second pipe 34 connected to the first pipe 32, instead of the bypass pipe 80 of the analytical apparatus 122 shown in Figure 3, and a third valve 64 is provided in the second pipe 34. In the concentration process, the third valve 64 can be opened to send permeate water to the flow injection system 40 through the second pipe 34. In the analysis process, the third valve 64 can be closed to stop the supply of permeate water, thereby sending only the concentrated sample water of the substance to be analyzed to the flow injection system 40. Furthermore, throughout the concentration and analysis processes, reagents are continuously supplied from the reagent injection unit 44 to the flow injection system 40 through the third pipe 36, making it possible to mix the reagents with the sample water.

[0051] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the second piping 34 may be connected to the upstream side of the second valve 62 of the discharge pipe 31, thereby sending a portion of the permeate from the concentration process to the second piping 34 and flowing it into the piping flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the discharge pipe 31 may be connected to the upstream side of the third valve 64 of the second piping 34 via the second valve 62, thereby discharging a portion of the permeate through the discharge pipe 31.

[0052] Next, with reference to Figure 5, we will describe the case in which the water to be analyzed is supplied in the backwashing direction of the membrane filtration device 16 during the analysis process, and the analyte is discharged from the concentration side. Figure 5 is a diagram showing an analysis device 124 of another embodiment of the present invention. In the analysis device 124, the downstream of the outlet 24 and the downstream of the discharge 26 of the membrane filtration device 16 have the same configuration as the analysis device 122 shown in Figure 3, so the same reference numerals are used for components that perform the same function, and redundant explanations are omitted.

[0053] The analyzer 124 includes a fourth pipe 38 and a fifth pipe 39. One end of the fourth pipe 38 is connected to pipe 18, and the other end is connected to the fifth pipe 39. A fourth valve 66 is also provided on the fourth pipe 38. One end of the fifth pipe 39 is connected to the discharge section 26. Permeate water can be discharged from the fifth pipe 39 to the outside of the analyzer 12. The fifth pipe 39 is also equipped with a second valve 62 downstream of the connection point with the fourth pipe 38. The pipe 18 is also equipped with a fifth valve 68 downstream of the connection point with the fourth pipe 38.

[0054] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the third pipe 36 may be connected upstream of the connection point between the fifth pipe 39 and the fourth pipe 38, thereby sending a portion of the permeate from the concentration process to the third pipe 36 and flowing it into the flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the fifth pipe 39 may be connected upstream of the reagent injection unit 44 of the third pipe 36 via a second valve 62, thereby discharging a portion of the permeate from the system through the fifth pipe 39.

[0055] In the analysis apparatus 124, during the concentration process, the fifth valve 68 is opened and the fourth valve 66 is closed. Then, the pre-concentration pump 14 supplies the water to be analyzed to the membrane filtration apparatus 16 via the piping 18. At this time, the flow of the water to be analyzed into the membrane filtration apparatus 16 is the same as in the analysis apparatus 122.

[0056] A concentration process is performed for a predetermined period, followed by an analysis process. During the analysis process, with the water to be analyzed being supplied to the piping 18, the fifth valve 68 is closed and the fourth valve 66 is opened. The water to be analyzed supplied to the piping 18 is supplied from the piping 18 through the fourth piping 38 and the fifth piping 39, and via the discharge section 26, to the membrane filtration device 16 in the opposite direction to the flow of permeate water in the concentration process. At this time, the flow path of the water to be analyzed formed by the closed fifth valve 68 and the open fourth valve 66 constitutes a backwash mechanism. The water to be analyzed supplied from the discharge section 26 into the membrane filtration device 16 passes through the filtration membrane inside the membrane filtration device 16, and the analytes accumulated inside the membrane filtration device 16 are discharged downstream from the concentrated water outlet section 24 of the membrane filtration device 16. At this time, similar to the analytical apparatus 122 shown in Figure 4, the first valve 60 is opened and the third valve 64 is closed, so the analyte pushed out by the water to be analyzed is sent to the flow injection system 40 as sample water via the first pipe 32. The permeate from the membrane filtration apparatus 16 in the analysis process is sent from the water supply unit 28 to the flow injection system 40 via the third pipe 36, and a reagent is added in the process by the reagent injection unit 44. In this way, by increasing the backwash water flow rate, the entire amount of endotoxin on the membrane surface of the ultrafiltration membrane can be pushed to the measurement side, so that fine particles can be pushed out without using hydrogen water or functional water containing chemicals. In addition, since there is no need to use functional water, the effect on the reactivity between endotoxin and reagent can be avoided.

[0057] Figure 6 shows an analytical apparatus 125 of another embodiment of the present invention. The analytical apparatus 125 shown in Figure 6 differs from the analytical apparatus 124 shown in Figure 5 in that the reagent is continuously supplied to the flow injection system 40 throughout the concentration and analysis processes. Therefore, the analytical apparatus 125 shown in Figure 6 has a second pipe 34 connected to the first pipe 32 instead of the bypass pipe 80 of the analytical apparatus 124 shown in Figure 5, and a third valve 64 is provided in the second pipe 34. In the concentration process, the third valve 64 can be opened to send permeate water to the flow injection system 40 through the second pipe 34. In the analysis process, the third valve 64 can be closed to stop the supply of permeate water, thereby sending only the sample water to the flow injection system 40. Furthermore, throughout the concentration and analysis processes, the reagent is continuously supplied from the reagent injection unit 44 to the flow injection system 40 through the third pipe 36, making it possible to mix the reagent with the sample water.

[0058] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the second pipe 34 may be connected upstream of the connection point between the fifth pipe 39 and the fourth pipe 38, and a portion of the permeate from the concentration process may be sent to the second pipe 34 and flowed into the flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the fifth pipe 39 may be connected upstream of the third valve 64 of the second pipe 34 via the second valve 62, and a portion of the permeate may be discharged outside the system through the fifth pipe 39.

[0059] Figure 7 is a schematic graph showing the concentration change of concentrated water measured by the analytical apparatus of this embodiment and the analytical apparatus of the prior art. The horizontal axis represents time t, and the vertical axis represents the concentration of the analyte C. The solid line shows the concentration change of concentrated water measured by the analytical apparatus 12 of this embodiment. The dashed line shows the concentration change of the analyte in the sample water measured by the analytical apparatus of the prior art (see, for example, Patent Document 3), which analyzes the analyte while concentrating it by continuously performing cross-flow filtration.

[0060] In FIG. 7, t 0 is the start time of the concentration step, t 1 is the start time of the analysis step (that is, the end time of the concentration step), and t 2 is the end time of the analysis step. Note that in FIG. 7, the arrival time of water from the membrane filtration device 16 to the analyzer 48 is 0 (zero), that is, the water discharged from the membrane filtration device 16 reaches the analyzer 48 immediately after being discharged.

[0061] In the analyzer 12 of the present embodiment, the concentration gradually increases from time t 1 , t p reaches the peak concentration C p , and then decreases toward time t 2 , so that the concentration peak in the analysis step is clearly observed. On the other hand, no concentration peak is observed in the analyzer according to the related art. This is because, in the present embodiment, when the analysis target concentrated in the membrane filtration device 16 by the concentration step is supplied to the flow injection system 40 in the analysis step, the concentration temporarily becomes high and a peak appears, while the conventional constant cross-flow filtration method shows little change in the concentration of the concentrated water.

[0062] In FIG. 7, a value obtained by multiplying the area of the figure surrounded by the graph between t 1 and t 2 , the time axis and the concentration axis by the flow rate in the analysis step indicates the number of analysis targets concentrated in the membrane filtration device 16 in the concentration step. From these facts, the concentration of the analysis target in the analysis target water can be expressed by the following formula (1).

[0063] (In formula (1), Δt is the differential of time t, C(t) is the measured value (concentration) of the analyzer 48 at time t, R is the supply flow rate of the analysis target water to the membrane filtration device 16 in the analysis step, R 0 is the supply flow rate of the analysis target water to the membrane filtration device 16 in the concentration step).

[0064] Figure 7 schematically represents the concentration change; in actual analysis, the concentration is calculated quantitatively using fluorescence intensity, etc. If a sufficient number of measurement points cannot be obtained (for example, if only one peak value is available), the concentration can be determined by one of the following methods. One method is to measure a standard sample of known concentration in advance, create a calibration curve based on the results, and measure the concentration by comparing it with the obtained peak value. Another method is to adjust the conditions so that the timing of endotoxin arrival at the flow injection system matches the timing of measurement by the flow injection system, and directly measure the peak value. In either method, if the supply flow rate changes, the timing of peak arrival will fluctuate, making accurate concentration measurement difficult. Therefore, it is preferable to keep the supply flow rate constant at all times.

[0065] Next, examples will be described. The present invention is not limited to the following examples.

[0066] In the examples, the endotoxin concentration of the analyte water was analyzed using an analytical apparatus 12 similar to that shown in Figure 1. The analyte water was prepared by adding endotoxin (standard endotoxin: MERCK, product number L2880) to water for injection to a concentration of 0.1 EU / mL (1 pM). Here, since the titer of 100 pg of endotoxin is generally equivalent to 1 EU, 100 EU / mL was converted to 1 nM. In the comparative example, the analysis was performed using an analytical apparatus described in Patent Document 3, which concentrates endotoxin by a conventional method of continuous cross-flow filtration. The ultrafiltration membrane used in the examples and comparative example had a molecular weight cutoff of 5 kDa and was made of modified polyethersulfone (MPES).

[0067] The permeate flow rate and concentrated water flow rate of the ultrafiltration membranes in the examples and comparative examples are as follows: (Examples) Permeate flow rate in the concentration step: 300 mL / min Concentrated water flow rate in the analysis step: 1 mL / min (Comparative Examples) Concentrated water flow rate: 0.95 mL / min Permeate flow rate (reagent side): 0.95 mL / min Permeate flow rate (discharge side): 300 mL / min In addition, the other analytical conditions in the examples and comparative examples are as follows. Note that the amount of endotoxin attached to the membrane surface is the amount of ET attached to the membrane surface when ET is accumulated by passing water through for 30 minutes. Amount of endotoxin attached to the membrane surface: 8 × 10 -10 (g / cm 2 ) Flow rate: 300 (mL / min) Analysis volume: 2 (mL / min) Analysis time: 10 (min) The specifications of the ultrafiltration apparatus used in the examples and comparative examples are as follows: Ultrafiltration apparatus: Membrane area 115 cm² 2 Ultrafiltration membrane with a nominal pore size of 5 kDa (MIDIKROS manufactured by Repligen, material: modified polyethersulfone (MPES), hollow fiber membrane).

[0068] In this example and comparative example, the measurement conditions were: excitation wavelength 350 nm, detection fluorescence wavelength 500 nm, fluorescent reagent Zn-dpa-C2OPy (see chemical formula (1) below), and fluorescent reagent concentration of 10 μM at the reagent injection section. The flow rate of the permeate water in the concentration step of the example was 300 mL / min, and the flow rate of the concentrated water in the analysis step was 1 mL / min.

[0069] The measurement conditions for the examples and comparative examples were an excitation wavelength of 350 nm and a detection fluorescence wavelength of 500 nm.

[0070] The measurement results for the examples and comparative examples are shown in Table 1.

[0071]

[0072] As shown in Table 1, a concentration peak was detected in the example. This concentration peak was similar to the one schematically shown in Figure 7. On the other hand, no concentration peak was detected in the comparative example. These results indicate that the endotoxin was concentrated in the example compared to the comparative example, and that it is possible to detect endotoxin by the flow injection system even in the low concentration range.

[0073] Next, Table 2 shows the relationship between the measured concentration ratio and flux when endotoxin analysis was performed under the conditions of Examples a, c and Comparative Example b below.

[0074] (Example a) - An analytical apparatus 12 similar to that shown in Figure 1 was used. - Analyte: ET standard solution 0.1 EU / mL - Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material MPES (modified polyethersulfone) - Filtration conditions: Total filtration, filtration time 15 minutes, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min - Flow rate in the analysis process: concentrated water 0.95 mL / min - Carrier water is ultrapure water, flow rate: 0.95 mL / min (Comparative example b) - An analytical apparatus described in Figure 1 of Japanese Patent No. 7606197 was used. - Analyte: ET standard solution 0.1 EU / mL - Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material MPES (modified polyethersulfone) - Filtration conditions: Cross-flow filtration, UF inlet pressure 0.16 MPa, Permeate flow rate 300 mL / min, flux 27 mm / min, concentrated water flow rate 0.95 mL / min. Carrier water is ultrapure water, flow rate: 0.95 mL / min (Example c). Flux 91 mm / min. Other operating conditions are the same as in Example a.

[0075]

[0076] The following findings were obtained from the results of the examples and comparative examples in Table 2. First, the total filtration method was shown to have a superior concentration ratio compared to the conventional cross-flow filtration method. This is thought to be because the endotoxins accumulated on the membrane surface are efficiently detached by backwashing or flushing.

[0077] Secondly, it was found that when the flux is too high, the highly dispersed state of endotoxin on the membrane surface cannot be maintained. This is thought to be the reason for the decrease in the measured concentration ratio.

[0078] Table 3 below shows the relationship between the measured endotoxin concentration ratio and the membrane material obtained under the following conditions for Examples (A) and (B) and Comparative Example (C). Example (A) - An analytical apparatus 12 similar to that shown in Figure 1 was used. - Analyte: ET standard solution 0.1 EU / mL - Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, membrane material: MPES (modified polyethersulfone) - Filtration conditions: total filtration, filtration time 15 minutes, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min - Flow rate during analysis: concentrated water 0.95 mL / min - Carrier water: ultrapure water flow rate: 0.95 mL / min Comparative Example (B) - An analytical apparatus described in Figure 1 of Patent No. 7606197 was used. - Analyte: ET standard solution 0.1 EU / mL - Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, membrane material: MPES (modified polyethersulfone) Filtration conditions: Cross-flow filtration, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min, concentrated water flow rate 0.95 mL / min Carrier water is ultrapure water Flow rate: 0.95 mL / min Example (C) UF membrane material changed to CA (cellulose acetate) Other conditions are the same as Example (A)

[0079]

[0080] The following findings were obtained from the results of the examples and comparative examples in Table 3. Compared to the cross-flow filtration method, the total filtration method showed a high measurement concentration ratio regardless of the membrane material, confirming good detection efficiency. Even under the same flow rate and flux conditions, differences in the measurement concentration ratio occurred depending on the membrane material used, suggesting that the selection of material is an important factor affecting analytical accuracy. In particular, MPES (modified polyethersulfone) showed the highest measurement concentration ratio and can be said to be suitable for endotoxin detection. CA (cellulose acetate) also showed a sufficient measurement concentration ratio and is considered to be a membrane material that can provide practically acceptable accuracy.

[0081] Table 4 below shows the relationship between the measured concentration ratio and the amount of endotoxin deposited under the following conditions for Examples (D), (E), and Comparative Example (F). Example (D) - An analytical apparatus 12 similar to that shown in Figure 1 was used. - Analyte: ET standard solution 0.1 EU / mL - Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material MPES (modified polyethersulfone) - Filtration conditions: total filtration, filtration time 15 minutes, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min - Flow rate during analysis: concentrated water 0.95 mL / min - Carrier water: ultrapure water flow rate: 0.95 mL / min - Amount deposited on the membrane: 7 × 10 -9 g / cm 2 Comparative Example (E) - Analytical apparatus as described in Figure 1 of Patent No. 7606197 was used. - Analyte: ET standard solution 0.1 EU / mL - Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material MPES (modified polyethersulfone) - Filtration conditions: Cross-flow filtration, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min, concentrated water flow rate 0.95 mL / min - Carrier water is ultrapure water: water volume 0.95 mm / min - Carrier water is ultrapure water flow rate: 0.95 mL / min - Amount of material attached to the membrane: 6 × 10 -12 g / cm 2 Example (F) • Permeate flow rate: 500 mL / min • Amount of material adhering to the membrane: 9 × 10 -5 g / cm 2 Other implementation conditions are the same as in Example (D).

[0082]

[0083] The following findings were obtained from the results of the examples and comparative examples in Table 4. In the total filtration method, there was a tendency for a larger amount of endotoxin to adhere to the membrane surface compared to the cross-flow method. This indicates that because all of the feedwater is filtered, endotoxin is more easily accumulated on the membrane surface. In addition, in example (F) where the permeate flow rate was increased, the amount of adhesion to the membrane increased significantly, suggesting that an increase in the supply flow rate affects the adhesion behavior. On the other hand, when the amount of adhesion to the membrane becomes excessive, the proportion of endotoxin that is guided out of the membrane by flushing in the analysis process decreases, and as a result, there was a tendency for the measured concentration ratio to decrease.

[0084] 12, 121, 122, 123, 124, 125...Analytical device, 14...Pre-concentration pump, 16...Membrane filtration device, 18, 32, 34, 36, 38, 39...Piping, 20...Outer cylinder, 22...Inlet, 24...Outlet, 26...Discharge, 28...Water supply, 30...Ultrafiltration membrane, 31...Discharge pipe, 40...Flow injection system, 42...Pump, 44...Reagent injection, 46...Merger pipe, 48...Analyzer, 50...Outlet pipe, 60, 62, 64, 66, 68...Valve, 70...Loop pipe, 80...Bypass piping

Claims

1. An analytical apparatus comprising: a flow injection system for reacting an analyte with a reagent in water and analyzing the analyte using the resulting reaction product; a membrane filtration device equipped with a microfiltration membrane or an ultrafiltration membrane; a concentration mechanism for accumulating the analyte in water within the membrane filtration device; a flushing mechanism for flowing the analyte accumulated in the membrane filtration device, together with the concentrated water from the membrane filtration device, into the flow injection system; a switching mechanism for switching between the concentration mechanism and the flushing mechanism; and a reagent injection unit for supplying the reagent to the flow injection system.

2. The analytical apparatus according to claim 1, wherein the concentration mechanism performs total filtration with the membrane filtration device.

3. The analytical apparatus according to claim 1, wherein the flushing mechanism flows the entire amount of the supply water from the membrane filtration device to the flow injection system from the concentration side.

4. The analytical apparatus according to claim 1, wherein the flushing mechanism flows 50% or more of the supply water of the membrane filtration device as concentrated water into the flow injection system.

5. The analytical apparatus according to claim 4, wherein the permeate from the membrane filtration apparatus flows from the reagent line to the flow injection system, and the reagent injection unit injects the reagent into the reagent line.

6. The analytical apparatus according to claim 1, wherein the switching mechanism alternately switches between the concentration mechanism and the flushing mechanism, enabling continuous analysis of the analyte.

7. The analytical apparatus according to claim 1, wherein the flushing mechanism includes a backwashing mechanism that supplies water from the permeate side of the membrane filtration apparatus and discharges the analyte from the concentration side of the membrane filtration apparatus.

8. The analytical apparatus according to any one of claims 1 to 7, wherein the flow injection system is capable of quantitative analysis of the analyte.

9. An analytical method for analyzing an analyte by reacting the analyte with a reagent in water to produce a reaction product, comprising: a concentration step of accumulating the analyte on a filtration membrane using one or more filtration membranes selected from microfiltration membranes and ultrafiltration membranes; and an analytical step of flowing the accumulated analyte together with the concentrated water from the filtration membrane into a flow injection system while flowing the reagent into the flow injection system.

10. The analytical method according to claim 9, wherein in the concentration step, the entire amount is filtered using the filtration membrane.

11. The analytical method according to claim 9, wherein the reagent is flowed through the flow injection system together with the permeate from the filtration membrane.

12. The analytical method according to claim 9, wherein, in the analytical step, the entire amount of the water supplied to the filtration membrane is flowed into the flow injection system as the concentrated water.

13. The analytical method according to any one of claims 9 to 12, wherein the analytical method is capable of quantitatively analyzing the analyte.

14. The analytical method according to any one of claims 9 to 12, wherein the concentration step and the analysis step are alternately switched to enable continuous analysis of the analyte.